Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sanofi
Fierce Biotech
FDA shares CRL for Sanofi MS drug mere weeks after rebuff
Less than two weeks after rejecting Sanofi’s investigational MS drug, the FDA has shared the CRL, citing both efficacy and safety concerns.
Gabrielle Masson
Jan 6, 2026 4:30am
Sanofi bolsters adult vaccine roster with $2.2B Dynavax purchase
Dec 29, 2025 10:24am
9 pharmas reach US drug price deals with Trump administration
Dec 19, 2025 3:35pm
Enhertu, ADC trial deaths, Takeda—Fierce Pharma Asia
Dec 19, 2025 8:00am
Merck, Sanofi, AZ shots for RSV now under scrutiny by FDA
Dec 9, 2025 11:52am
ASH: Pfizer's Hympavzi reduces bleeding in hemophilia patients
Dec 6, 2025 4:00pm
